Statistical analysis of quality of life with missing data in cancer clinical trials.
about
The use of bootstrap methods for analysing Health-Related Quality of Life outcomes (particularly the SF-36)Reporting missing participant data in randomised trials: systematic survey of the methodological literature and a proposed guideAlternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients.Analysing longitudinal continuous quality of life data with dropout.Can electronic web-based technology improve quality of life data collection? Analysis of Radiation Therapy Oncology Group 0828.PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions.Simple imputation methods were inadequate for missing not at random (MNAR) quality of life dataPROMIS Fatigue Item Bank had Clinical Validity across Diverse Chronic ConditionsMissing data methods for dealing with missing items in quality of life questionnaires. A comparison by simulation of personal mean score, full information maximum likelihood, multiple imputation, and hot deck techniques applied to the SF-36 in the FEvaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel mPatient-reported outcomes and survivorship in radiation oncology: overcoming the consTime to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study.Patient-reported outcomes in a phase iii study of everolimus versus placebo in patients with metastatic carcinoma of the kidney that has progressed on vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy.Acupuncture and the relaxation response for treating gastrointestinal symptoms in HIV patients on highly active antiretroviral therapy.Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial.The PROMIS satisfaction with social participation measures demonstrated responsiveness in diverse clinical populationsClinical validity of PROMIS Depression, Anxiety, and Anger across diverse clinical samples.Estimation of regression models for the mean of repeated outcomes under nonignorable nonmonotone nonresponse.Evidence from diverse clinical populations supported clinical validity of PROMIS pain interference and pain behavior.Validity of PROMIS physical function measured in diverse clinical samples.Reporting on quality of life in randomised controlled trials in gastrointestinal surgeryQuality-of-life concerns in lung cancer patients.Ovarian cancer study dropouts had worse health-related quality of life and psychosocial symptoms at baseline and over time.Imputation of missing values in the case of a multiple item instrument measuring alcohol consumption.Comparison of CTT and Rasch-based approaches for the analysis of longitudinal Patient Reported Outcomes.Patterns of missing mini mental status exam (MMSE) in radiation therapy oncology group (RTOG) brain cancer trials.Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).
P2860
Q24798183-BD664003-021D-4AC4-9C8A-CE96AD6CC7DFQ28076913-CD9554CC-3F30-4A4E-B36B-653B279D50CBQ30665974-A6F85578-479F-4417-A7D6-6F5D4FC1CDC2Q30683663-41D7F17D-783C-4389-AFE7-75A58DF7A94DQ30809152-9ED61384-424B-4C12-BE43-8A22B03779BAQ30830391-3D5CBD52-2C24-407F-8C6D-966BB0DF7393Q31168964-983A139E-E8AE-4174-8F87-D3CB7EB323BEQ33458017-94211A02-15D6-4B21-989C-569A3F9DF968Q33706317-B14CE4E4-B0BF-4498-8C05-DCB7E64CCF06Q34020507-F471A381-DE80-4238-9284-7111E96F3107Q34124311-BAC9DD95-9F9E-4C10-9486-D42E25AA0AF0Q34807981-50C2A74C-712C-46D7-A34F-197B1302D102Q35079333-A81FE5F0-BA83-4662-8FA3-D7D47F8A39ACQ35584879-90119FCE-2744-47C3-8F43-B94C9DDEBECAQ35596698-84281C26-949D-4783-8EBE-49DEE1F3FC93Q36889650-02E8EC37-3DCE-49EC-8B24-703325805E0BQ36994033-5C270512-6EFB-4CD3-A119-CB3F1180CAC7Q37055706-55B8B415-235E-4FA0-9042-8E9E54DEDF36Q37114138-C6EC4430-7674-4F4E-B20B-548F7ADBFBB0Q37119010-7B96F540-3EE0-4CA6-BC4D-9ECCDF2B38C8Q37141677-B8100FC8-3314-4B02-867C-987ED37E0654Q37614291-C1DADDAA-D3E5-40D5-8CC9-12096544CCD8Q37820679-B79B35FA-6F7D-42A0-BB0A-2B1982422ACEQ39442127-643BBDAE-58C4-4A5F-AD1A-5752475E1F72Q43685083-B884C363-D077-494E-8F92-744ABEF3D3B9Q43854286-F7FB5CD4-2C33-438B-9CE6-F7CB2F66FD81Q46917381-F8A59D69-64CB-4EF8-86DA-25B09E02BA88Q48048391-F83E1B8A-6380-4B3A-B13B-5320A9A32DC0
P2860
Statistical analysis of quality of life with missing data in cancer clinical trials.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Statistical analysis of quality of life with missing data in cancer clinical trials.
@ast
Statistical analysis of quality of life with missing data in cancer clinical trials.
@en
type
label
Statistical analysis of quality of life with missing data in cancer clinical trials.
@ast
Statistical analysis of quality of life with missing data in cancer clinical trials.
@en
prefLabel
Statistical analysis of quality of life with missing data in cancer clinical trials.
@ast
Statistical analysis of quality of life with missing data in cancer clinical trials.
@en
P2093
P1476
Statistical analysis of quality of life with missing data in cancer clinical trials.
@en
P2093
P304
P356
10.1002/(SICI)1097-0258(19980315/15)17:5/7<653::AID-SIM812>3.0.CO;2-M
P407
P577
1998-03-01T00:00:00Z